ライフサイエンスコーパス: glomerular filtration

1 f parathyroid hormone at a rate that exceeds glomerular filtration.

2 secretion of solutes is more efficient than glomerular filtration and a major mechanism for renal dr

3 tiple studies supports the concept that both glomerular filtration and proximal tubule (PT) reclamati

4 To better understand these roles of glomerular filtration and PT uptake, we investigated the

5 due to loss of podocytes, cells critical for glomerular filtration, and leads to proteinuria and kidn

6 ution the ultrastructural alterations of the glomerular filtration apparatus in mice lacking the crit

7 plexes in a subepithelial location along the glomerular filtration barrier 14 days after antibody inj

8 ritically involved in the maintenance of the glomerular filtration barrier and are key targets of inj

9 ocytes are essential components of the renal glomerular filtration barrier and podocyte dysfunction l

10 ant role in maintaining the integrity of the glomerular filtration barrier and preventing urinary pro

11 ified fatty acids (NEFAs) across the damaged glomerular filtration barrier and subsequent reabsorptio

12 Nephrotic syndrome (NS) occurs when the glomerular filtration barrier becomes excessively permea

13 ic deletion of Fat1 in mice induces abnormal glomerular filtration barrier development, leading to po

14 to a universal end point of podocyte injury, glomerular filtration barrier disruption, and SRNS.

15 Podocytes are important for glomerular filtration barrier function and maintenance o

16 ltered podocyte differentiation and impaired glomerular filtration barrier function, with development

17 needed to define its role in maintenance of glomerular filtration barrier integrity.

18 ogies and usually caused by deterioration of glomerular filtration barrier integrity.

19 a, suggesting an important role of THSD7A in glomerular filtration barrier integrity.

20 The glomerular filtration barrier is known as a 'size cutoff

21 Disruption of any component of the glomerular filtration barrier leads to glomerular dysfun

22 Ultrastructurally, the glomerular filtration barrier of the Gsalpha-deficient a

23 intaining the integrity of podocytes and the glomerular filtration barrier of the kidney.

24 The mechanisms by which the glomerular filtration barrier prevents the loss of large

25 culating proteins, suggesting failure of the glomerular filtration barrier sieving properties, or dif

26 ntified YAP as an essential component of the glomerular filtration barrier that promotes podocyte sur

27 These lesions and dysfunction of the glomerular filtration barrier were associated with FSGS

28 SRNS), a heterogeneous disorder of the renal glomerular filtration barrier, results in impairment of

29 ith those from neighboring cells to form the glomerular filtration barrier.

30 sential for maintaining the integrity of the glomerular filtration barrier.

31 glomeruli that act as a key component of the glomerular filtration barrier.

32 iated epithelial cells that reside along the glomerular filtration barrier.

33 l for the development and maintenance of the glomerular filtration barrier.

34 is essential for the maintenance of a normal glomerular filtration barrier.

35 se podocyte effacement and impairment of the glomerular filtration barrier.

36 podocytes represent a key constituent of the glomerular filtration barrier.

37 al tubular secretion function correlate with glomerular filtration, but substantial variability in ne

38 On the basis of reduced glomerular filtration, glycosuric and weight loss effect

39 Worsening in estimated glomerular filtration more than 20% was observed in 2294

40 s defined as an annual decrease in estimated glomerular filtration more than 20%.

41 of therapeutic maneuvers aimed at restoring glomerular filtration need to be examined in relation to

42 ine (Pnoninferiority = 0.0004), and measured glomerular filtration (Pnoninferiority = 0.0003).

43 percent of the participants had an estimated glomerular filtration rate >30 mL/min per 1.73 m(2).

44 We selected adult subjects with an estimated glomerular filtration rate >60 mL/min/1.73m(2), an outpa

45 ents with normal or impaired renal function (glomerular filtration rate >80 mL/min or between 80 and

46 sidered if chronic kidney disease (estimated glomerular filtration rate < 45 mL/min/1.73 m(2)) or pro

47 ey disease (serum creatinine level >3 mg/dL; glomerular filtration rate <15 mL/min; acute kidney inju

48 , >1 g proteinuria, heart failure, estimated glomerular filtration rate <20 mL.min(-1).1.73 m(-2), or

49 proteinuria daily, heart failure, estimated glomerular filtration rate <20 ml/min/1.73 m(2), or rece

50 se, renal death, development of an estimated glomerular filtration rate <30 mL/min per 1.73m(2), or d

51 Among 1512 patients with estimated glomerular filtration rate <30 mL/min/1.73m(2), 35.4% fi

52 ndicated AHM use for patients with estimated glomerular filtration rate <30 mL/min/1.73m(2).

53 oup had borderline renal function (estimated glomerular filtration rate <45 mL/min/1.73 m(2)) and hep

54 ients with chronic kidney disease (estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2)).

55 ification of Diet in Renal Disease-estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2)).

56 pants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min per 1.73 m(2) or u

57 ng within 1 year in ACHD included: estimated glomerular filtration rate <60 ml/min/1.73 m(2) (hazard

58 t hoc analysis of subjects with an estimated glomerular filtration rate <60 ml/min/1.73 m(2), a first

59 in patients with RD, defined as an estimated glomerular filtration rate <60 mL/min/1.73 m(2), and com

60 pnea, and any of the following: 1) estimated glomerular filtration rate <60 ml/min/1.73 m(2); 2) hypo

61 pants with chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2) receiving

62 e main outcome was CKD, defined as estimated glomerular filtration rate <60 mL/minute/1.73 m(2) (usin

63 with and without renal impairment (estimated glomerular filtration rate <60mL/min/1.73m(2)).

64 Low estimated glomerular filtration rate (<40 mL/min/1.73 m(2)) and pr

65 (beta, 0.70; P < .001), and higher estimated glomerular filtration rate (beta, 0.03; P = .02).

66 of lithium maintenance therapy on estimated glomerular filtration rate (eFGR) in patients with affec

67 tinine ratio >/=300 mg/g), reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2), an

68 lished cardiovascular disease, and estimated glomerular filtration rate (eGFR) >/=30 mL.min(-1).1.73

69 D Among 3 570 865 US veterans with estimated glomerular filtration rate (eGFR) >/=60 mL min(-1) 1.73

70 whereas positively associated with estimated glomerular filtration rate (eGFR) (all P < 0.05).

71 I: 1.99-4.80), moderately impaired estimated glomerular filtration rate (eGFR) (HR = 1.76, 95% CI: 1.

72 inine level and cystatin C-derived estimated glomerular filtration rate (eGFR) and assessment of prot

73 e effects of MRP inhibitors on the estimated glomerular filtration rate (eGFR) and proximal tubular f

74 Estimated glomerular filtration rate (eGFR) has been reported to b

75 is of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 European an

76 PM2.5 exposure was associated with estimated glomerular filtration rate (eGFR) in a cohort of older m

77 The mean estimated glomerular filtration rate (eGFR) increased over the 7-y

78 ebrovascular disease and preserved estimated glomerular filtration rate (eGFR) is not established.

79 Individuals with >/=2 estimated glomerular filtration rate (eGFR) measurements after 1 F

80 (stages 3 and 4) was defined as an estimated glomerular filtration rate (eGFR) of 15 to 59 mL/min/1.7

81 compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min or greate

82 compensated cirrhosis, and with an estimated glomerular filtration rate (eGFR) of 40 mL/min or greate

83 6662 participants with a baseline estimated glomerular filtration rate (eGFR) of at least 60 mL/min/

84 oncentrations and risk of incident estimated glomerular filtration rate (eGFR) of less than 60 mL/min

85 patients with a prehospitalization estimated glomerular filtration rate (eGFR) of more than 45 mL/min

86 etween the AMS and post-transplant estimated glomerular filtration rate (eGFR) using mixed models, co

87 of 6 y, we assessed kidney volume, estimated glomerular filtration rate (eGFR) using serum creatinine

88 166 (73.1%) had diabetes, the mean estimated glomerular filtration rate (eGFR) was 33.9 +/- 15.8 ml/m

89 The change of estimated glomerular filtration rate (eGFR) with off-treatment nuc

90 y the association of pre-operative estimated glomerular filtration rate (eGFR) with PPCs in laparosco

91 ividuals from four ancestries, for estimated glomerular filtration rate (eGFR), a measure of kidney f

92 ion/primary nonfunction (DGF/PNF), estimated glomerular filtration rate (eGFR), and graft-survival at

93 enome-wide association studies for estimated glomerular filtration rate (eGFR), combining data across

94 renal outcomes: >/=30% decline in estimated glomerular filtration rate (eGFR), doubling of the serum

95 y function, as measured by reduced estimated glomerular filtration rate (eGFR), has been associated w

96 comes were HbA1c, LDL cholesterol, estimated glomerular filtration rate (eGFR), incident microalbumin

97 inverse correlation between CI and estimated glomerular filtration rate (eGFR), such that higher CI w

98 Albuminuria, but not estimated glomerular filtration rate (eGFR), was associated with i

99 is session for predicting 12-month estimated glomerular filtration rate (eGFR).

100 of coffee and tea consumption with estimated glomerular filtration rate (eGFR).

101 albuminuria) and rate of change of estimated glomerular filtration rate (eGFR).

102 relation to kidney function, as assessed by glomerular filtration rate (eGFR).

103 y relevant decline (>/=25%) in the estimated glomerular filtration rate (eGFR).

104 mal renal function, as measured by estimated glomerular filtration rate (eGFR).

105 d cystatin C-based measures of the estimated glomerular filtration rate (eGFR).

106 ation by body mass index (BMI) and estimated glomerular filtration rate (eGFR).

107 isease (CKD) is defined by reduced estimated glomerular filtration rate (eGFR).

108 rectly associated with declines in estimated glomerular filtration rate (eGFR).

109 Estimated glomerular filtration rate (eGFR, a marker of kidney fun

110 abetes mellitus and inversely with estimated glomerular filtration rate (eGFRcreatcysC)(all P < 0.001

111 Estimated glomerular filtration rate (eGRF) was inversely correlat

112 acid (PUA) levels are associated with lower glomerular filtration rate (GFR) and higher blood pressu

113 lized changes from baseline in the estimated glomerular filtration rate (GFR) and measured GFR were -

114 as conducted to determine if TRPC6 regulates glomerular filtration rate (GFR) and the contractile fun

115 udy of the effects of dietary salt intake on glomerular filtration rate (GFR) and tubular Na(+) reabs

116 The glomerular filtration rate (GFR) assesses the function o

117 There was no significant change in glomerular filtration rate (GFR) before or after therapy

118 dney volume and the decline in the estimated glomerular filtration rate (GFR) but also caused more el

119 rfiltration is a risk factor for accelerated glomerular filtration rate (GFR) decline and nephropathy

120 The glomerular filtration rate (GFR) decreased in both group

121 Purpose The glomerular filtration rate (GFR) is essential for carbop

122 dition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min

123 late ion transport in response to changes in glomerular filtration rate (GFR) to maintain glomerulotu

124 pulation and determined the best theoretical glomerular filtration rate (GFR) to use in this estimati

125 Mean preoperative glomerular filtration rate (GFR) was 75.1 +/- 14.9 mL/mi

126 The glomerular filtration rate (GFR) was directly measured (

127 Glomerular filtration rate (GFR) was measured annually.

128 inaccuracy of creatinine-based estimates of glomerular filtration rate (GFR), UK and international g

129 This association could be attributable to glomerular filtration rate (GFR), which is related to PF

130 nt differences between "true" and calculated glomerular filtration rate (GFR).

131 tagonists may be associated with a decreased glomerular filtration rate (GFR).

132 This study examines the change in glomerular filtration rate (GFR, mL/min per m) in the fi

133 001) or biliary cancer (HR 12.7, P < 0.001), glomerular filtration rate (HR 0.89, P = 0.002), hyperte

134 th active/acute ABMR had a 3-month estimated glomerular filtration rate (median,: 43 mL/min) lower th

135 We tested if measured glomerular filtration rate (mGFR, by chrome-ethylenediam

136 ction or severe graft dysfunction: estimated glomerular filtration rate (Modification of Diet in Rena

137 min creatinine ratio (P < 0.01), the fall in glomerular filtration rate (P < 0.001), and improved ren

138 mass index (p = 0.001), and had a lower mean glomerular filtration rate (p < 0.001).

139 ysis, serum uric acid (P = 0.001), estimated glomerular filtration rate (P = 0.027), and VCAM (P = 0.

140 r SD increase; OR, 1.13; 95% CI, 1.05-1.21), glomerular filtration rate (per SD increase; OR, 0.67; 9

141 d to be negatively correlated with estimated glomerular filtration rate (R = -0.47, P < .001).

142 tinine clearance (median change in estimated glomerular filtration rate -1.8 mL/min [IQR -7.8 to 6.0]

143 he absence of diagnostic criteria (estimated glomerular filtration rate [eGFR] >60 ml/min/1.73 m2 and

144 ts with baseline renal impairment (estimated glomerular filtration rate [eGFR] </= 60 mL/min) and pai

145 disease (CKD, defined as confirmed estimated glomerular filtration rate [eGFR] </= 60 ml/min/1.73 m2)

146 ed prevalence of renal impairment (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m2), al

147 c kidney disease (serum creatinine estimated glomerular filtration rate [eGFR] <90 mL/min/1.73 m2 or

148 easures of chronic kidney disease (estimated glomerular filtration rate [eGFR] and albuminuria) with

149 1-2 chronic kidney disease (CKD) (estimated glomerular filtration rate [eGFR], >/= 60 mL/min/1.73 m(

150 showed a 1.5-fold higher level of estimated glomerular filtration rate and a fourfold lower level of

151 redictors of BTP levels are quinolinic acid, glomerular filtration rate and age.

152 We tested the hypothesis that decreased glomerular filtration rate and albuminuria have differen

153 Changes in the estimated glomerular filtration rate and albuminuria were also ana

154 Glomerular filtration rate and blood creatinine were not

155 ransplant outcomes included 1-year estimated glomerular filtration rate and death-censored graft surv

156 f >50% reduction in their baseline estimated glomerular filtration rate and end stage kidney disease

157 d in those with higher BMI, higher estimated glomerular filtration rate and lower creatinine.

158 ates, cf-PWV and AI were associated with the glomerular filtration rate and osteonecrosis.

159 The glomerular filtration rate and plasma renin, noradrenali

160 Estimated glomerular filtration rate and proteinuria are predictor

161 Patients with both low estimated glomerular filtration rate and proteinuria had highest r

162 rimary care, serum creatinine with estimated glomerular filtration rate and proteinuria measurements

163 proximately 17 mm Hg in both groups, whereas glomerular filtration rate and renal blood flow were dec

164 rogressive reduction in renal blood flow and glomerular filtration rate and showed evidence of renal

165 llograft fibrosis and with reduced estimated glomerular filtration rate at 12 months after transplant

166 t function had significantly lower estimated glomerular filtration rate at 12 months postbiopsy and a

167 chronic rejection, or in the mean estimated glomerular filtration rate at 15 years.

168 The changes in serum potassium and estimated glomerular filtration rate at 24, 48, 72, and 96 hours.

169 a significant benefit for graft survival and glomerular filtration rate at 5 years (P < 0.0001).

170 h delayed graft function and lower estimated glomerular filtration rate at end follow-up.

171 at least 100 x 10(9) platelets per L, and a glomerular filtration rate at least 60 mL/min.

172 failure by ICD9 code or laboratory-confirmed glomerular filtration rate below 60 ml/min.

173 al function decline (>20% decrease estimated glomerular filtration rate between 6 months and last fol

174 and 30, there was no difference in estimated glomerular filtration rate between the RF study group an

175 ons in dietary Na(+) intake do not alter the glomerular filtration rate but alter the total and cell-

176 acute, dose-dependent reduction in estimated glomerular filtration rate by approximately 5 mL.min(-1)

177 , respectively) and similar across estimated glomerular filtration rate categories but was significan

178 ession, administration of SRT3025 attenuated glomerular filtration rate decline and proteinuria witho

179 APOL1-associated estimated glomerular filtration rate decline was observed starting

180 ysis, transplantation, and/or >60% estimated glomerular filtration rate decline, or mortality) outcom

181 ndomization to month 36, mean (SD) estimated glomerular filtration rate decreased by 7.0 (31.3) mL/mi

182 Reduced glomerular filtration rate defines chronic kidney diseas

183 Age and basal glomerular filtration rate did not differ between groups

184 n should reflect ongoing baseline, discharge glomerular filtration rate estimated from creatinine con

185 when estimated from cystatin C compared with glomerular filtration rate estimated from creatinine, 44

186 atinine consistently overestimated follow-up glomerular filtration rate estimated from creatinine, wh

187 mated from creatinine, whereas ICU discharge glomerular filtration rate estimated from cystatin C wel

188 Median 1-year estimated glomerular filtration rate for DBD donor kidneys was low

189 The adjusted change in mean estimated glomerular filtration rate from baseline to month 6 (Nan

190 ificant for death, 25% decrease in estimated glomerular filtration rate from baseline, major adverse

191 (95% CI 0.003-0.02; p < 0.005) in estimated glomerular filtration rate from serum creatinine, 0.01 g

192 dney transplantation patients with estimated glomerular filtration rate greater than 90 have worse ou

193 ould be used for the evaluation of estimated glomerular filtration rate in patients with stabilized s

194 whereas positively associated with estimated glomerular filtration rate in patients.

195 at 3 years posttransplant (loss of estimated glomerular filtration rate in the chemoprophylaxis cohor

196 st histological predictor for posttransplant glomerular filtration rate in the LAT group was the exte

197 olic blood pressure decreased, and estimated glomerular filtration rate increased (P=0.003) more in t

198 In association, the glomerular filtration rate increased significantly excep

199 rapy discontinuation when baseline estimated glomerular filtration rate is above 44 mL/min/1.73 m.

200 Patients with estimated glomerular filtration rate less than 15 mL/min/1.73 m or

201 th end-stage nonrenal disease with estimated glomerular filtration rate less than 30 mL/min per 1.73

202 Patients with mean baseline estimated glomerular filtration rate less than 45 mL/min/1.73 m we

203 rtension, 32% had LVH, and 38% had estimated glomerular filtration rate less than 60 mL/min per 1.73

204 discharge, almost twice as many patients had glomerular filtration rate less than 60 mL/min/1.73 m wh

205 0 mg/dL, cystatin C >/=1.11 mg/dL, estimated glomerular filtration rate less than 60 mL/min/1.73 m, a

206 with type 2 diabetes and CKD (with estimated glomerular filtration rate less than 60 mL/min/1.73 m2),

207 onic kidney disease was defined as estimated glomerular filtration rate less than 60 mL/min/1.73 m2,

208 me was incident CKD, defined as an estimated glomerular filtration rate less than 60 mL/min/1.73 m2.

209 Forty (1%) had measured glomerular filtration rate less than 80 mL/min; 32 (1%)

210 t after 1 January 2007; CKD was defined as a glomerular filtration rate of <60 mL/min/1.73 m(2).

211 history of coronary heart disease, estimated glomerular filtration rate of 20 to 59 ml/min/1.73 m(2),

212 ort study recruited adults with an estimated glomerular filtration rate of 20 to 70 mL/min/1.73 m2 fr

213 95% CI, 1.05-1.51) and decrease in estimated glomerular filtration rate of 30% or more (11,045 events

214 bling of creatinine or decrease in estimated glomerular filtration rate of 30% or more.

215 V-1 RNA <50 copies per mL) with an estimated glomerular filtration rate of 50 mL per min or greater,

216 , lamivudine, and abacavir; and an estimated glomerular filtration rate of 50 mL/min or more.

217 function was excellent with a mean estimated glomerular filtration rate of 54 mL per min after 1 year

218 e of graft function (difference in estimated glomerular filtration rate of 9.6 mL/min per 1.73 m(2) a

219 tients with type 2 diabetes and an estimated glomerular filtration rate of at least 30 ml per minute

220 V-1 RNA >/=500 copies per mL) with estimated glomerular filtration rate of at least 30 mL/min.

221 of at least 100 cells per muL, and estimated glomerular filtration rate of at least 90 mL/min per 1.7

222 a reduction of 50% or more in the estimated glomerular filtration rate or end-stage graft failure.

223 o significant difference in 1-year estimated glomerular filtration rate or graft failure between grou

224 rhosis and ascites; rifaximin did not affect glomerular filtration rate or levels of vasoactive hormo

225 ompared with those with either low estimated glomerular filtration rate or proteinuria (18.7%) and th

226 ratios; 95% CIs) were age (1.13; 1.06-1.20), glomerular filtration rate per 5-U increments (0.93; 0.9

227 Estimated glomerular filtration rate remained lower in group II co

228 7 y, 52% were female, and the mean estimated glomerular filtration rate was 31 +/- 9 mL . min(-1) . 1

229 ncrease in spherical equivalent or estimated glomerular filtration rate was associated with a 0.70-mi

230 Estimated glomerular filtration rate was calculated using the Modi

231 No change in estimated glomerular filtration rate was noted after the procedure

232 Baseline estimated glomerular filtration rate was the only one predictor of

233 aft and patient survival, and mean estimated glomerular filtration rate were also comparable between

234 mortality, and >/= 30% decline in estimated glomerular filtration rate were examined using Cox propo

235 terstitial inflammation score, and estimated glomerular filtration rate were significantly worse in u

236 nificant association between eGFR (estimated glomerular filtration rate) and serum sclerostin levels

237 5-30 mL/min/1.73 m(2)) or stage 5 (estimated glomerular filtration rate, <15 mL/min/1.73 m(2) or requ

238 ssure, lipid profile, retinopathy, estimated glomerular filtration rate, (micro)albuminuria, the use

239 0.80; interquartile range, 0.70-1.01 mg/dL; glomerular filtration rate, 102+/-23; median, 106; inter

240 outpatients with type 2 diabetes (estimated glomerular filtration rate, 15 to <60 mL/min/1.73 m2 and

241 ut cirrhosis and with CKD stage 4 (estimated glomerular filtration rate, 15-30 mL/min/1.73 m(2)) or s

242 all, 1461 (10%) had CKD (mean [SD] estimated glomerular filtration rate, 49 [10] mL/min/1.73 m2).

243 (n = 50) matched for age, sex, and estimated glomerular filtration rate, and 23 renal transplant reci

244 term follow-up, 1 had a normalized estimated glomerular filtration rate, and 3 (4%) had persistent CK

245 contrast, blood pressure lowering, estimated glomerular filtration rate, and albuminuric effects are

246 d urea nitrogen, serum creatinine, estimated glomerular filtration rate, and blood chemistry variable

247 10) who were matched for age, sex, estimated glomerular filtration rate, and date of MR imaging exami

248 ment should have serum creatinine, estimated glomerular filtration rate, and electrolytes measurement

249 nger, with higher body mass index, estimated glomerular filtration rate, and forced expiratory volume

250 but a higher rate of porcelain aorta, lower glomerular filtration rate, and higher mean Society of T

251 Patients with lower blood pressure, lower glomerular filtration rate, and more severe heart failur

252 fibroblast growth factor 23 level, estimated glomerular filtration rate, and proteinuria, the hazard

253 albumin, high-density lipoprotein, estimated glomerular filtration rate, and QTc interval.

254 ni-x and sham sheep, mean arterial pressure, glomerular filtration rate, and renal blood flow were me

255 ulatory support, natriuretic peptide decile, glomerular filtration rate, and total bilirubin level we

256 h-density lipoprotein cholesterol, estimated glomerular filtration rate, antihypertensive therapy, di

257 y and postdonation renal function (estimated glomerular filtration rate, eGFR) of the remaining kidne

258 gh-sensitivity C-reactive protein, estimated glomerular filtration rate, elevated TMAO levels remaine

259 higher in the presence of a lower estimated glomerular filtration rate, higher albuminuria, hyperten

260 lder age, diabetes mellitus, lower estimated glomerular filtration rate, higher heart rate, prior myo

261 wer systolic blood pressure, lower estimated glomerular filtration rate, higher N-terminal pro-B-type

262 ood pressure, BMI, smoking status, estimated glomerular filtration rate, LDL-cholesterol concentratio

263 ards models adjusted for age, sex, estimated glomerular filtration rate, left ventricular ejection fr

264 holesterol, antihypertensive medication use, glomerular filtration rate, left ventricular mass index,

265 daily blocks walked, diuretic use, estimated glomerular filtration rate, left ventricular mass, eject

266 , progression of retinopathy, changes in the glomerular filtration rate, lipid levels, and measures o

267 fter adjusting for age, race, sex, estimated glomerular filtration rate, liver volume, and total kidn

268 itions characterized by a sudden decrease in glomerular filtration rate, manifested by an increase in

269 Microalbuminuria, glomerular filtration rate, mesangial cell expansion, an

270 l class, diastolic blood pressure, estimated glomerular filtration rate, N-terminal pro-B-type natriu

271 thickness, other cardiovascular markers, the glomerular filtration rate, or progression of retinopath

272 No effects on the glomerular filtration rate, P = 0.14, or vasoactive horm

273 renal composite (40% reduction in estimated glomerular filtration rate, renal replacement therapy, o

274 YHA functional class (III vs. II), estimated glomerular filtration rate, responders to chemotherapy,

275 in cholesterol, hemoglobin A1c, albuminuria, glomerular filtration rate, smoking, and exercise.

276 f a sustained 40% reduction in the estimated glomerular filtration rate, the need for renal-replaceme

277 .0044), while the routinely used parameters (glomerular filtration rate, urine albumin-to-creatinine

278 with creatine clearance, 0.54 with estimated glomerular filtration rate-Cockcroft-Gault).

279 e drugs modified according to bodyweight and glomerular filtration rate.

280 topathies and its expression correlates with glomerular filtration rate.

281 oking, elevated triglycerides, and estimated glomerular filtration rate.

282 698 outcomes of >/= 30% decline in estimated glomerular filtration rate.

283 for age, sex, body mass index, and estimated glomerular filtration rate.

284 expression, which correlated with declining glomerular filtration rate.

285 atified by HbA1c, BMI, region, and estimated glomerular filtration rate.

286 l function, regardless of baseline estimated glomerular filtration rate.

287 sma glucose, high total cholesterol, and low glomerular filtration rate; 72.4%, 95% UI 70.2-73.5) and

288 nd without hypertension and normal estimated glomerular filtration rates (eGFR) during 2005 and 2006,

289 Cr levels and glomerular filtration rates (GFRs) were grouped accordin

290 red) renal allograft survival with estimated glomerular filtration rates (mL/min per 1.73 m) of 43 to

291 Estimated glomerular filtration rates (Modification of Diet in Ren

292 censored for primary nonfunction, estimated glomerular filtration rates after 1 year and 5 years wer

293 function imaging, where blood velocities and glomerular filtration rates are simultaneously measured,

294 ents on belatacept has demonstrated superior glomerular filtration rates as compared with CNIs, albei

295 atients had significantly worse (P < 0.0001) glomerular filtration rates at 1, 2, 3, and 4 years post

296 In this subpopulation, estimated glomerular filtration rates at randomization were higher

297 nts of at least 200 cells per muL, estimated glomerular filtration rates of at least 70 mL per min, a

298 , including the entire spectrum of estimated glomerular filtration rates.

299 LK and LAT patients had comparable estimated glomerular filtration rates.

300 Hip and spine bone mineral density and glomerular filtration were each significantly improved i